Related Experiment Videos
Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease
1Ophthalmology Section, Department of Plastic Surgery, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. besmaeli@mdanderson.org
American Journal of Ophthalmology
|December 4, 2001
Abstract
Purpose:
To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha.
Methods:
Interventional case report.
Results:
The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy.
Conclusion:
Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.